GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BIMI International Medical Inc (STU:63N) » Definitions » Debt-to-EBITDA

BIMI International Medical (STU:63N) Debt-to-EBITDA : -0.36 (As of Sep. 2023)


View and export this data going back to . Start your Free Trial

What is BIMI International Medical Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

BIMI International Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was €1.87 Mil. BIMI International Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was €2.32 Mil. BIMI International Medical's annualized EBITDA for the quarter that ended in Sep. 2023 was €-11.61 Mil. BIMI International Medical's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 was -0.36.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for BIMI International Medical's Debt-to-EBITDA or its related term are showing as below:

STU:63N' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -25.99   Med: -0.27   Max: 13.96
Current: -0.41

During the past 13 years, the highest Debt-to-EBITDA Ratio of BIMI International Medical was 13.96. The lowest was -25.99. And the median was -0.27.

STU:63N's Debt-to-EBITDA is ranked worse than
100% of 427 companies
in the Healthcare Providers & Services industry
Industry Median: 2.63 vs STU:63N: -0.41

BIMI International Medical Debt-to-EBITDA Historical Data

The historical data trend for BIMI International Medical's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIMI International Medical Debt-to-EBITDA Chart

BIMI International Medical Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.07 -1.57 -0.27 -0.30

BIMI International Medical Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.38 -0.17 -1.68 0.86 -0.36

Competitive Comparison of BIMI International Medical's Debt-to-EBITDA

For the Pharmaceutical Retailers subindustry, BIMI International Medical's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BIMI International Medical's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BIMI International Medical's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where BIMI International Medical's Debt-to-EBITDA falls into.



BIMI International Medical Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

BIMI International Medical's Debt-to-EBITDA for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2.422 + 2.728) / -16.961
=-0.30

BIMI International Medical's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.873 + 2.315) / -11.612
=-0.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2023) EBITDA data.


BIMI International Medical  (STU:63N) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


BIMI International Medical Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of BIMI International Medical's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


BIMI International Medical (STU:63N) Business Description

Traded in Other Exchanges
Address
Chongqing Corporation Avenue, 9th Floor, Building 2, Yuzhong District, Chongqing, CHN, 400010
BIMI International Medical Inc is a healthcare product and provider, offering a broad range of healthcare products and related services and operates private hospitals in China. The company is engaged in four business segments, Pharmaceuticals wholesale, Medical devices wholesale, Medical services, and Pharmacy retail. It generates maximum revenue from the pharmaceuticals wholesale segment. It mainly sources its products from large state-owned pharmaceutical manufacturers and wholesalers and mid-sized or small private pharmaceutical manufacturers and wholesalers. The Company's revenues were generated in the PRC.

BIMI International Medical (STU:63N) Headlines

No Headlines